Inhibition of cerebral vasospasm by intracranial delivery of ibuprofen from a controlled-release polymer in a rabbit model of subarachnoid hemorrhage.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Neurosurgery

• Publication date

  2004-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3171/JNS.2004.101.1.0093PMID 15255257
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of intercellular adhesion molecule 1 (ICAM-1) on the cerebral artery following subarachnoid haemorrhage in rats

  2005cited by this paper
• On Controlled Delivery

  2004cited by this paper
• Cerebral Vasospasm after Subarachnoid Hemorrhage: Putative Role of Inflammation

  2003cited by this paper
• High-dose ibuprofen for reduction of striatal infarcts during middle cerebral artery occlusion in rats.

  2003cited by this paper
• Inhibition of vasospasm with lymphocyte function-associated antigen-1 monoclonal antibody in a femoral artery model in rats.

  2002cited by this paper
• Prevention of Experimental Cerebral Vasospasm by Intracranial Delivery of a Nitric Oxide Donor From a Controlled-Release Polymer: Toxicity and Efficacy Studies in Rabbits and Rats

  2002cited by this paper
• Rise in serum soluble intercellular adhesion molecule-1 levels with vasospasm following aneurysmal subarachnoid hemorrhage.

  2002cited by this paper
• Outcome prediction with serum intercellular adhesion molecule-1 levels after aneurysmal subarachnoid hemorrhage.

  2002cited by this paper
• Prevention and Reversal of Experimental Posthemorrhagic Vasospasm by the Periadventitial Administration of Nitric Oxide from a Controlled-release Polymer

  2001cited by this paper
• Cocaine Use Is an Independent Risk Factor for Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage

  2001cited by this paper
• Etiology of cerebral vasospasm.

  1999cited by this paper
• Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans.

  1999cited by this paper
• Inhibition of experimental vasospasm in rats with the periadventitial administration of ibuprofen using controlled-release polymers.

  1999cited by this paper
• Structure and function of P-selectin glycoprotein ligand-1.

  1998cited by this paper
• Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits.

  1998cited by this paper
• Inhibition of leukocyte adhesion: an alternative mechanism of action for anti-inflammatory drugs.

  1998cited by this paper
• Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage.

  1998cited by this paper
• Inducible cyclooxygenase expression in canine basilar artery after experimental subarachnoid hemorrhage.

  1998cited by this paper
• Aneurysmal subarachnoid hemorrhage: prognostic features and outcomes.

  1997cited by this paper
• Endothelial cell expression of intercellular adhesion molecule 1 in experimental posthemorrhagic vasospasm.

  1997cited by this paper
• Inhibition of experimental vasospasm with anti-intercellular adhesion molecule-1 monoclonal antibody in rats.

  1997cited by this paper
• Ibuprofen inhibits pyrogen-dependent expression of VCAM-1 and ICAM-1 on human endothelial cells.

  1996cited by this paper
• Cerebral arterial spasm--a clinical review.

  1995cited by this paper
• Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain.

  1993cited by this paper
• The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes.

  1991cited by this paper
• The role of inflammation in experimental cerebral vasospasm.

  1990cited by this paper
• Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system.

  1990cited by this paper
• Endothelins, peptides with potent vasoactive properties, are produced by human macrophages

  1990cited by this paper
• Brain biocompatibility of a biodegradable, controlled-release polymer in rats.

  1989cited by this paper
• Controlled delivery of 1,3-bis(2-chloroethyl)-1-nitrosourea from ethylene-vinyl acetate copolymer.

  1989cited by this paper
• Secretory products of macrophages.

  1987cited by this paper
• Inhibition of human polymorphonuclear leukocyte functions by ibuprofen.

  1987cited by this paper
• The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system.

  1987cited by this paper
• Angiographic evidence of basilar artery constriction in the rabbit: a new model of vasospasm.

  1987cited by this paper
• Regulated expression of the Mac-1, LFA-1, p150,95 glycoprotein family during leukocyte differentiation.

  1986cited by this paper
• Cerebral vasospasm following aneurysmal subarachnoid hemorrhage.

  1985cited by this paper
• The role of the prostacyclin-thromboxane system in cerebral vasospasm following induced subarachnoid hemorrhage in the rabbit.

  1984cited by this paper
• Prevention of chronic experimental cerebral vasospasm with ibuprofen and high-dose methylprednisolone.

  1983cited by this paper
• Cerebral artery spasm. A histological study at necropsy of the blood vessels in cases of subarachnoid hemorrhage.

  1978cited by this paper
• Time course of vasospasm in man.

  1978cited by this paper
• Reversal of experimental cerebral vasospasm by intravenous nitroprusside therapy.

  1976cited by this paper
• Electrocardiographic changes and tissue catecholamines in experimental subarachnoid haemorrhage.

  1969cited by this paper

• Aneurysmal subarachnoid haemorrhage—cerebral vasospasm and prophylactic ibuprofen: a randomised controlled pilot trial protocol

  2022cites this paper
• The role of immune inflammation in aneurysmal subarachnoid hemorrhage.

  2020cites this paper
• Effectiveness of low-dose intravenous fentanyl for postoperative headache management after neck clipping of ruptured intracranial aneurysms: Fentanyl for post-subarachnoid hemorrhage headache.

  2020cites this paper
• Pain control after aneurysmal subarachnoid hemorrhage: A contemporary literature review.

  2019cites this paper
• Novel Treatments in Neuroprotection for Aneurysmal Subarachnoid Hemorrhage

  2016cites this paper
• Influencia de la hemodilución en la evolución de pacientes con hemorragia subaracnoidea aguda espontanea

  2016cites this paper
• A Propensity Score-Matched Study of the Use of Non-steroidal Anti-inflammatory Agents Following Aneurysmal Subarachnoid Hemorrhage

  2016cites this paper
• Curcumin, encapsulated in nano-sized PLGA, down-regulates nuclear factor κB (p65) and subarachnoid hemorrhage induced early brain injury in a rat model.

  2015cites this paper
• Comparative Efficacy of Meloxicam and Placebo in Vasospasm of Patients with Subarachnoid Hemorrhage

  2015cites this paper
• Inflammation, Vasospasm, and Brain Injury after Subarachnoid Hemorrhage

  2014cites this paper
• Simvastatin Attenuates Experimental Cerebral Vasospasm and Ameliorates Serum Markers of Neuronal and Endothelial Injury in Patients After Subarachnoid Hemorrhage : A Dose-Response Effect Dependent on Endothelial Nitric Oxide Synthase

  2014cites this paper
• Vasospasm in Cerebral Inflammation

  2014cites this paper
• The Impact of Nonsteroidal Anti-inflammatory Drugs on Inflammatory Response After Aneurysmal Subarachnoid Hemorrhage

  2014cites this paper
• Semantic Breakthrough in Drug Discovery

  2014cites this paper
• A glutamate receptor antagonist, S-4-carboxyphenylglycine (S-4-CPG), inhibits vasospasm after subarachnoid hemorrhage in haptoglobin 2-2 mice [corrected].

  2013cites this paper
• Inflammation, Cerebral Vasospasm, and Evolving Theories of Delayed Cerebral Ischemia

  2013cites this paper
• Systemic L-citrulline prevents cerebral vasospasm in haptoglobin 2-2 transgenic mice after subarachnoid hemorrhage.

  2012cites this paper
• Endovascular management of cerebral vasospasm post-subarachnoid hemorrhage

  2012cites this paper
• Targeting the brain: advances in drug delivery.

  2012cites this paper
• Neuroimaging Assessment of Cerebral Vasospasm

  2012cites this paper
• Non-steroidal anti-inflammatory drugs used as a treatment modality in subarachnoid hemorrhage.

  2012cites this paper
• Purine anti-metabolite attenuates nuclear factor κB and related pro-inflammatory cytokines in experimental vasospasm

  2012cites this paper
• Site-Specific, Sustained-Release Drug Delivery for Subarachnoid Hemorrhage

  2012cites this paper
• Mining Relational Paths in Integrated Biomedical Data

  2011cites this paper
• The effects of clenbuterol on cerebral vasospasm in an experimental rat model of subarachnoid hemorrhage.

  2011cites this paper
• Doppler- (TCD) und Duplexsonographie (TCCD) in der Diagnostik und im Therapieverlauf von Vasospasmen nach aneurysmatischer Subarachnoidalblutung

  2010cites this paper
• 6-Mercaptopurine attenuates adhesive molecules in experimental vasospasm

  2010cites this paper
• Inflammation and cerebral vasospasm after subarachnoid hemorrhage.

  2010cites this paper
• Role of inflammation (leukocyte-endothelial cell interactions) in vasospasm after subarachnoid hemorrhage.

  2010cites this paper
• Percutaneous transluminal angioplasty in a patient with vasospasm secondary to coccidioidal meningitis: case report and review of the literature

  2010cites this paper
• CONTROLLED DELIVERY OF NITRIC OXIDE INHIBITS LEUKOCYTE MIGRATION AND PREVENTS VASOSPASM IN HAPTOGLOBIN 2‐2 MICE AFTER SUBARACHNOID HEMORRHAGE

  2009cites this paper
• Neuroendovascular management of vasospasm following aneurysmal subarachnoid hemorrhage.

  2009cites this paper
• Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a single-institution prospective cohort study.

  2009cites this paper
• Prevention of cerebral vasospasm by local delivery of cromakalim with a biodegradable controlled-release system in a rat model of subarachnoid hemorrhage.

  2009cites this paper
• Novel treatments for cerebral vasospasm following aneurysmal subarachnoid hemorrhage.

  2008influential citation
• Anti-inflammatory effect of meloxicam on experimental vasospasm in the rat femoral artery.

  2008cites this paper
• TREATMENT OF CEREBRAL VASOSPASM WITH BIOCOMPATIBLE CONTROLLED‐RELEASE SYSTEMS FOR INTRACRANIAL DRUG DELIVERY

  2008influential citation
• A review of medical treatments of cerebral vasospasm

  2008cites this paper
• Attenuation of experimental subarachnoid hemorrhage-induced increases in circulating intercellular adhesion molecule-1 and cerebral vasospasm by the endothelin-converting enzyme inhibitor CGS 26303.

  2007cites this paper
• DELAYED CEREBRAL VASOSPASM SECONDARY TO BACTERIAL MENINGITIS AFTER LUMBOSACRAL SPINAL SURGERY: CASE REPORT

  2007cites this paper
• Advances in vasospasm treatment and prevention.

  2007cites this paper
• SYSTEMIC ADMINISTRATION OF PHOSPHODIESTERASE V INHIBITOR, SILDENAFIL CITRATE, FOR ATTENUATION OF CEREBRAL VASOSPASM AFTER EXPERIMENTAL SUBARACHNOID HEMORRHAGE

  2006cites this paper
• Safe and efficient drug delivery system with liposomes for intrathecal application of an antivasospastic drug, fasudil.

  2006cites this paper
• Vasospasm in aneurysmal subarachnoid hemorrhage: diagnosis, prevention, and management.

  2006cites this paper
• A review of current and future medical therapies for cerebral vasospasm following aneurysmal subarachnoid hemorrhage.

  2006cites this paper
• Leukocyte-endothelial cell interactions in chronic vasospasm after subarachnoid hemorrhage

  2006cites this paper
• Controlled release of lipopolysaccharide in the subarachnoid space of rabbits induces chronic vasospasm in the absence of blood.

  2006cites this paper
• Systemic Administration of Simvastatin after the Onset of Experimental Subarachnoid Hemorrhage Attenuates Cerebral Vasospasm

  2006cites this paper
• Endovascular Management of Intracranial Aneurysms: Current Experience and Future Advances

  2006cites this paper
• Controlled release of a nitric oxide donor for the prevention of delayed cerebral vasospasm following experimental subarachnoid hemorrhage in nonhuman primates.

  2005cites this paper
• Local Delivery of Ibuprofen via Controlled-release Polymers Prevents Angiographic Vasospasm in a Monkey Model of Subarachnoid Hemorrhage

  2005influential citation